Condition

Haematological Malignancy clinical trials and research

• 15Clinical trials
• 10Countries

Newest Haematological Malignancy clinical trials

All recruiting trials (15)

• Dabrafenib and trametinib for rare cancers with BRAF V600 mutations

  This arm tests whether dabrafenib and trametinib can help adults, children, and teens with cancers that have a BRAF V600 mutation.

  Recruiting at 15 sites Phase 2/3 Cancer Research UK · Belfast and 26 other locations · NCT07440290

• Capmatinib treatment for adults with cancers having MET gene changes

  This study is testing if capmatinib, a drug for lung cancer, can help adults with different types of cancers that have changes in the MET gene.

  Recruiting at 16 sites Phase 2/3 Cancer Research UK · Belfast and 16 other locations · NCT06988475

• Home management program for patients with blood cancers after chemotherapy

  This study tests a new home care program for patients with blood cancers after high-dose chemotherapy to see if it helps them recover better while allowing them to leave the hospital sooner.

  Recruiting IRCCS Azienda Ospedaliero-Universitaria di Bologna · Bologna, Bologna · NCT06814405

• Pharmacogenomics to improve voriconazole dosing for fungal infections

  This trial will test whether using a patient's CYP2C19 genotype with Bayesian dosing software helps get voriconazole levels into the therapeutic range by Day 8 for people with fungal infections, including those with blood cancers.

  Recruiting at 7 sites Phase 2 The University of Queensland · Seattle, Washington and 6 other locations · NCT06510699

• Combination of trastuzumab and pertuzumab for treating cancers with HER2 mutations

  This study is testing if a combination of two cancer drugs, trastuzumab and pertuzumab, can help adults and young people with cancers that have HER2 mutations or amplifications.

  Recruiting at 24 sites Phase 2/3 Cancer Research UK · Belfast and 26 other locations · NCT05786716

• Entrectinib treatment for patients with ROS1-positive cancers

  This study is testing if the drug entrectinib can help people with different types of cancers that have a ROS1 gene fusion, including adults and kids, to see if it works better than what’s currently available.

  Recruiting at 24 sites Phase 2/3 Cancer Research UK · Belfast and 26 other locations · NCT05770544

• Alectinib treatment for ALK-positive cancers in adults and children

  This study is testing if alectinib, a drug for lung cancer, can help treat different types of ALK-positive cancers in both adults and children.

  Recruiting at 24 sites Phase 2/3 Cancer Research UK · Belfast and 26 other locations · NCT05770037

• Combination of vemurafenib and cobimetinib for treating BRAF positive cancers

  This study is testing if the combination of vemurafenib and cobimetinib can help adults with different types of cancers that have a specific BRAF mutation.

  Recruiting at 16 sites Phase 2/3 Cancer Research UK · Belfast and 15 other locations · NCT05768178

• Evaluating existing drugs for rare cancers with specific genetic changes

  This study is testing if approved cancer drugs can help people with rare cancers or common cancers that have specific genetic changes feel better and live longer.

  Recruiting at 26 sites Phase 2/3 Cancer Research UK · Belfast and 26 other locations · NCT05722886

• Genomic profiling for targeted treatment in patients with incurable cancer

  This study is testing if using genetic information from tumors can help find better treatment options for people with incurable cancer.

  Recruiting Aalborg University Hospital · Aalborg · NCT05695638

• Testing if stopping immunoglobulin therapy and using antibiotics can prevent infections in blood cancer patients

  This study is testing if blood cancer patients can safely stop their immunoglobulin therapy after six months and use antibiotics instead to prevent infections.

  Recruiting at 5 sites Phase 2/3 Monash University · Garran, Australian Capital Territory and 6 other locations · NCT05678621

• Adapted physical activity for recovery after stem cell transplantation

  This study tests if doing six sessions of adapted physical activity at home can help people recovering from stem cell transplants lose weight and improve their quality of life.

  Recruiting Centre Hospitalier Universitaire de Nice · Nice · NCT05379738

• Understanding Ocular Graft-Versus-Host Disease After Bone Marrow Transplant

  This study is trying to understand how common eye problems are in people who have had a bone marrow transplant and see if certain factors can help improve their care.

  Recruiting The University of Hong Kong · Hong Kong · NCT05170347

• Facilitating access to targeted anti-cancer drugs for advanced cancer patients

  This study is testing whether targeted anti-cancer drugs can help patients with advanced cancer who have specific genetic markers, while also making it easier for them to access these treatments.

  Recruiting at 5 sites Phase 2 Helsinki University Central Hospital · Turku, Southwest Finland and 4 other locations · NCT05159245

• Evaluating CCS1477 for blood cancers

  This study is testing a new drug called CCS1477 to see if it can help people with certain blood cancers who haven't responded to other treatments.

  Recruiting at 34 sites Phase 1/2 CellCentric Ltd. · Atlanta, Georgia and 38 other locations · NCT04068597

Related topics

Quick answers

How many Haematological Malignancy clinical trials are recruiting right now?

15, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.

Where are these trials running?

In 10 countries. The most sites are in United Kingdom (8 trials), Australia (2 trials), United States (2 trials), France (2 trials), Italy (1 trial). Each study page lists its sites and which ones are recruiting.

What phases are they in?

Phase 2/3: 8, Phase 2: 2, Phase 1/2: 1. Trials with no phase listed are usually device, behavioural or observational studies.

How do I join one?

Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.

Find the studies that fit you

A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.

Describe your situation →